NCT07171554 - Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2029

Conditions

Metastatic Colorectal Cancer (mCRC)

Interventions

DIAGNOSTIC_TEST

µCAN drug screen test

µCAN guided therapy is based on drug screening of patient-derived tumoroids. The patient might be treated with clinically relevant on-label or off-label drugs

OTHER

Standard-of-Care Therapy

trifluridine/tipiracil/bevacizumab combination, 28 day cycles

Trial Locations (1)

1478

Akershus University Hospital, Lørenskog